2-(苯甲酰氨基)-4-甲基吡啶 | 13021-71-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(苯甲酰氨基)-4-甲基吡啶
• 英文名称: N-benzyl-4-methylpyridin-2-amine
• 英文别名: 2-Benzylamino-4-methylpyridine
• CAS: 13021-71-1
• 化学式: C₁₃H₁₄N₂
• mdl: MFCD00006253
• 分子量: 198.268
• InChiKey: QHDJYTUZWBABGW-UHFFFAOYSA-N

物化性质

• 熔点：
  98-100°C (lit.)
• 沸点：
  342.7±27.0 °C(Predicted)
• 密度：
  1.107±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.153
• 拓扑面积：
  24.9
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 2-Benzylamino-4-methylpyridine
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 13021-71-1

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Skin irritation (Category 2), H315
Eye irritation (Category 2), H319
Specific target organ toxicity - single exposure (Category 3), Respiratory system, H335
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xi Irritant R36/37/38
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.
Precautionary statement(s)
Avoid breathing dust.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Substances
Formula : C13H14N2
Molecular Weight : 198,26 g/mol
CAS-No. : 13021-71-1
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
2-Benzylamino-4-methylpyridine
Skin Irrit. 2; Eye Irrit. 2; STOT -
SE 3; H315, H319, H335
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
2-Benzylamino-4-methylpyridine
Xi, R36/37/38 -
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: powder
Colour: yellow
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 98 - 100 °C - lit.
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(苯甲酰氨基)-4-甲基吡啶 在 二(叔丁基羰基氧基)碘苯 作用下， 反应 7.0h， 以98%的产率得到3-甲基吡啶并[1,2-a]苯并咪唑
  参考文献：
  名称：

  通过C–C和C–N键断裂的N-苄基-2-氨基吡啶的无金属串联脱甲基/ C（sp 2）–H环氨基化过程

  摘要：

  已经开发了一种轻度，无金属的合成方法，该方法以N-苄基-2-氨基吡啶为原料，以PhI（OPiv）2为化学计量氧化剂，合成了吡啶并[1,2- a ]苯并咪唑类化合物。该过程由一个不寻常的岛（OPiv）发起2介导的本位小号ë的Ar反应，接着进行溶剂辅助C-C和C-N键断裂。

  DOI：

  10.1021/ol4015656
• 作为产物：
  描述：

  2-氨基-4-甲基吡啶 在 sodium tetrahydroborate 、 1-butyl-3-methylimidazolium Tetrafluoroborate 作用下， 反应 5.0h， 生成 2-(苯甲酰氨基)-4-甲基吡啶
  参考文献：
  名称：

  A mild method for the regioselective bromination of 2-aminopyridines

  摘要：

  DOI：

  10.1016/j.tetlet.2014.07.050

文献信息

• Nickel(II)–N^ΛN^ΛO Pincer Type Complex-Catalyzed N-alkylation of Amines with Alcohols via the Hydrogen Autotransfer Reaction
  作者：Gunasekaran Balamurugan、Rengan Ramesh、Jan Grzegorz Malecki

  DOI：10.1021/acs.joc.0c00530

  日期：2020.6.5

  A highly sustainable catalytic protocol for the coupling of alcohols and amines for selective monoalkylated amines using Ni(II)–NΛNΛO pincer type complexes through the borrowing hydrogen methodology is described. An array of Ni(II) catalysts (1–3) was synthesized and characterized by various spectral and analytical methods. Furthermore, the distorted square planar geometry of the complexes (1 and 2)

  对于醇和胺选择性的耦合甲高度可持续催化协议用Ni（II）-N单烷基化胺Λ Ñ Λ ö钳型配合物通过借用氢方法进行说明。合成了一系列Ni（II）催化剂（1-3），并通过各种光谱和分析方法对其进行了表征。此外，配合物（1和2）用单晶X射线衍射研究证实。廉价的镍基催化方法论显示了使用多种伯醇对芳族和杂芳族胺进行N-烷基化的广泛底物范围，产率高达97％。本方法对环境无害，它释放水作为唯一的副产物。药物中间体（如美吡拉敏和氯吡胺）的简短合成说明了本方案的实用性。
• Copper-catalyzed direct amination of benzylic hydrocarbons and inactive aliphatic alkanes with arylamines
  作者：Hua Yao、Bo Xie、Xiaoyang Zhong、Shengzhou Jin、Sen Lin、Zhaohua Yan

  DOI：10.1039/d0ob00491j

  日期：——

  A new synthetic method toward direct C-N bond formation through saturated C-H amination of benzylic hydrocarbons and inactive aliphatic alkanes with primary aromatic amines under an inexpensive catalyst/oxidant (Cu/DTBP) system has been developed. Both aminopyridines and anilines could react smoothly with primary and secondary benzylic C-H substrates or cyclohexane to form the corresponding aromatic

  在廉价的催化剂/氧化剂（Cu / DTBP）系统下，已经开发出一种新的合成方法，该方法可通过苄基烃和惰性脂肪族烷烃与伯芳族胺的饱和CH胺化直接形成CN键。氨基吡啶和苯胺均可与伯和仲苄基CH底物或环己烷顺利反应，以中等至良好的收率形成相应的芳族仲胺。该协议的优点是宽泛的官能团耐受性和使用现成的原料。
• Bidentate geometry-constrained iminopyridyl nickel-catalyzed synthesis of amines or imines via borrowing hydrogen or dehydrogenative condensation
  作者：Yong Jiang、Miao Hu、Nan Sun、Baoxiang Hu、Zhenlu Shen、Xinquan Hu、Liqun Jin

  DOI：10.1016/j.tetlet.2020.152604

  日期：2020.12

  efficient Ni-catalyzed N-alkylation of various anilines with alcohols via borrowing hydrogen is reported using a bidentate geometry-constrained iminopyridyl nickel complex as the catalyst. Substituted benzylic alcohols and short/long chain aliphatic alcohols could be applied as the alkylation sources to couple with aromatic and heteroaromatic amines to give a diverse set of N-alkylation outcomes in moderate

  报道了使用双齿几何约束的亚氨基吡啶基镍配合物作为催化剂，通过借入氢用醇对各种苯胺与醇的有效的Ni催化的N-烷基化。取代的苄醇和短/长链脂族醇可以用作烷基化源，与芳族和杂芳族胺偶联，以中等至极好的收率得到各种N-烷基化结果。镍催化体系也适用于脂肪族胺，可通过无受体脱氢缩合策略选择性地输送相应的亚胺。
• Hemilabile N-heterocyclic carbene (NHC)-nitrogen-phosphine mediated Ru (II)-catalyzed N-alkylation of aromatic amine with alcohol efficiently
  作者：Xiao-Jun Yu、Hai-Yu He、Lei Yang、Hai-Yan Fu、Xue-Li Zheng、Hua Chen、Rui-Xiang Li

  DOI：10.1016/j.catcom.2017.03.007

  日期：2017.5

  a novel N-heterocyclic carbene (NHC)-nitrogen-phosphine ligand (1) was synthesized, and the combination of it with [Ru(COD)Cl2]n showed the high activity and selectivity with a low Ru loading of 0.1% for the N-alkylation of amine with alcohol. Especially, for these substrates with pyridine backbone, even if the catalyst loading was as low as 0.01%, good yields (81–95%) of the desired products were

  基于半定性，合成了新型的N-杂环卡宾（NHC）-氮-膦配体（1），并与[Ru（COD）Cl 2 ] n结合使用具有较高的活性和选择性，且Ru较低。胺与醇的N-烷基化反应的负载量为0.1％。特别是，对于具有吡啶骨架的这些底物，即使催化剂的负载量低至0.01％，也可以实现所需产物的良好收率（81–95％）。
• [EN] EIF4E INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS D'EIF4E ET LEURS UTILISATIONS
  申请人：PIC THERAPEUTICS INC

  公开号：WO2021178488A1

  公开（公告）日：2021-09-10

  The present invention provides compounds inhibiting elF4E activity and compositions and methods of using thereof.

  本发明提供了抑制elF4E活性的化合物以及使用它们的组合物和方法。